Short-chain fatty acids in nonalcoholic fatty liver disease: New prospects for short-chain fatty acids as therapeutic targetsXinyu Li, Yaling Zhu, Xinrui Yi et al.|Heliyon|2024Cited by 68
Epigenetic Association Study Uncovered H3K27 Acetylation Enhancers and Dysregulated Genes in High-Fat-Diet-Induced Nonalcoholic Fatty Liver Disease in RatsJinhu Ma, Yaling Zhu, Xiaohui Wei et al.|Epigenomics|2022Cited by 25
Loss of <i>LBP</i> triggers lipid metabolic disorder through H3K27 acetylation-mediated C/EBPβ-<i>SCD</i> activation in non-alcoholic fatty liver diseaseYaling Zhu, Zichen Song, Xin Yuan et al.|动物学研究|2023Cited by 18
Genome‐Wide Profiling of H3K27ac Identifies <i>TDO2</i> as a Pivotal Therapeutic Target in Metabolic Associated Steatohepatitis Liver DiseaseYaling Zhu, Tiantian Zhang, Bu‐Chun Zhang et al.|Advanced Science|2024Cited by 9